Advancements in dry eye management
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA accepts Outlook Therapeutics' resubmitted BLA for ONS-5010 (LYTENAVA)
2
Tinlarebant NDA submission completed for Stargardt disease type 1, targeting first approved therapy
3
Study finds mixed real and synthetic eye images enhance ocular AI performance
4
IOLs: What Every Surgeon Needs to Know | Ep. 2: Enhanced monofocal IOLs
5